Board and Committee

Ugo Amaldi

Ugo Amaldi is a member of the ADAM Board of Directors. He has been Research Director and a researcher at Istituto di Sanità (the Italian Health Institute) and, later, at CERN. He has published more than 400 papers about the physics of atoms nuclei and particles, of radiations and their production and detection, and theoretical physics. His most known paper on the unification of the fundamental forces has been quoted 1200 times.

From 1980 to 1993 he created and directed the DELPHI collaboration which, formed of about 500 physicists coming from 20 countries, built and operated at the CERN elecronpositron collider LEP, the large detector bearing the same name. Chair professor of Medical physics, he has taught this subject in Florence and Milan University.

Founder and President of the TERA Foundation since its creation in 1992, in the last 15 years he has concentrated on developing techniques of cancer therapy which make use of beams of charged hadrons. To date, more than one million Italian high school pupils have studied his physics text books. He is Doctor honoris causa of the University of Helsinki, Lyon, Valencia and Uppsala and is member of the Italian Academy of Sciences.

Hans von Celsing

Hans von Celsing has over 30 years of experience from the Life Science Industry, primarily in the medical technology sector where he has co-founded and managed the growth and development of several (12) companies including fundraising and venture capital.

Jonathan Farr

Jonathan Farr received his PhD degree from Wayne State University in 2003 and completed his Habilitation (an advanced post-graduate qualification subsequent to a doctorate) in novel radiation oncology techniques at the Universitätsklinikum Essen-Duisburg, Germany in 2012. He has contributed to the development, characterisation and application of numerous particle therapy systems. Dr. Farr has served as chief of medical physics at the Westdeutsches Protonentherapiezentrum, Essen, Germany, and at the St. Jude Children’s Research Hospital, USA. He is board certified by the American Board of Radiology in Therapeutic Physics, has published over 45 papers in peer-reviewed journals and presented over 130 abstracts at scientific conferences.

Ed Lee

Ed Lee has had progressive responsibilities in manufacturing and operations over the last 20+ years. In his last role, he led the Production (Operations) and Technical Field Service teams for Optivus Proton Therapy by implementing best practices and programme/project management methodologies. His manufacturing and operational experiences span high- volume/low-mix to low-volume/high-mix industries such as Automotive, Aerospace, Military/ Defence, Nuclear, and Medical Device.

Stephen MYERS

Stephen was born in Belfast, N. Ireland. He was responsible for the commissioning and energy upgrade of the Large Electron Positron Collider (LEP).

In 2008, he became Director of Accelerators and Technology until January 2014; during this time, he directed the repair of the LHC after the serious accident and steered the operation of the collider in 2010, 2011, and 2012. On July 4, 2012 the collider allowed the discovery of a “Higgs” boson.

He is currently Executive Chairman of ADAM SA.

He has received many awards; honorary doctorates from the University of Geneva and the Queen’s University of Belfast, the IOP Duddell Medal, and the 2010 International Particle Accelerator Achievement prize. In 2012 he was joint recipient of the European Physical Society “EPS Edison Volta prize”, and in June 2013 was awarded an OBE for services to science. In October 2013, he was jointly awarded the “Prince of Asturias” Prize (Spain).


Dr. Sinclair qualified in medicine from the Middlesex Hospital, London in 1967 and held a number of appointments at teaching hospitals in London. He became a Registrar in Psychiatry at the Maudsley Hospital and Institute of Psychiatry of London University before entering business in 1971.

Between 1971 and 1977 he held senior board positions with Allied Investments Limited, which had operating interests in nursing homes through Nestor Nursing Homes, nursing agencies through the British Nursing Association, deputising services for doctors, medical equipment distribution, the management of hospitals for governments in the Middle East and the operation of a health spa.

In 1979, he founded Sinclair Montrose Trust Limited as a private investment vehicle for him and his family. Dr Sinclair was chairman and founder of Lifetime Corporation Inc, a New York Stock Exchange listed healthcare company. He serves on the Board of Overseers (emeritus) of the Tufts University School of Medicine. He was also the chairman and founder of US based Atlantic Medical Management LLP, which managed the New York based healthcare venture fund, Atlantic Medical Capital LP. He is the Chairman of AIM traded company, Totally Plc.


Enrico Vanni holds an engineering degree in chemistry from the Federal Polytechnic School of Lausanne, Switzerland, a Ph.D. in chemistry from the University of Lausanne, as well as a Master of Business Administration from INSEAD in Fontainebleau, France. He began his career as a research engineer at International Business Machines Corp. in California, United States, and joined McKinsey & Company in Zurich in 1980. He managed the Geneva office for McKinsey from 1988 to 2004, and consulted for companies in the pharmaceutical, consumer and finance sectors. He led McKinsey’s European pharmaceutical practice and served as member of the partner review committee of the firm prior to his retirement in 2007.

Since his retirement as director of McKinsey & Company in 2007, Enrico Vanni has been an independent consultant. He is currently a Vice Chairman of the Novartis Board of Directors. He is also a member of several boards of directors, in industries from healthcare to private banking for non-listed companies including Eclosion2, Denzler & Partners SA, Lombard Odier SA and Banque Privée BCP (Suisse) SA, all based in Switzerland.


Mr. Wolf has spent more than 35 years of his career in international commerce and industry, working closely with companies dealing with pharmaceuticals, minerals, metals, mining, oil and gas, hospitality, and real estate. He holds a Business degree from Middlesex University.